Kenya to Engage Russia in Seeking Covid-19 Vaccine As Cases Top 27,425

11 August 2020

Nairobi — Kenya said it will also engage Russia in seeking the newly developed COVID-19 vaccine, the first globally.

Health CAS Dr Mercy Mwangangi said the government will follow protocols through the Foreign Affairs Ministry.

"We definitely will plug in and work with Russia to ensure that the vaccine is safe before we use it," she told a news conference.

Dr Mwangangi has warned of the need to increase protective measures, after Kenya recorded 497 new cases, raising the country's tally to 27,425.

372 more patients were cleared after recovering from COVID-19, including 57 from hospitals. Others were on home-based care.

'"On a sad note, I wish to announce that we have lost 15 patients," she said. 11 had underlying conditions. So far, 438 people have died of COVID-19 in Kenya.

She said counties have made good progress in preparing for COVID-19 response, while warning of an upsurge of cases, particularly Nairobi which has been identified as the virus epicentre.

Kremlin officials said the country already have an order of 1 billion doses from 20 countries, just hours after announcing the vaccine's effectiveness in suppressing the virus that has killed over 700,000 people globally and infected more than 20 million. Just over 12 million others have recovered.

But now there is hope for COVID-19 patients after Russia announced that it had produced the first vaccine.

On Tuesday, President Vladimir Putin said his country had become the first to approve a vaccine offering "sustainable immunity" against the coronavirus and that one of his daughters has been inoculated.

The announcement came after scientists in the West raised concerns about the speed of development of Russian vaccines, suggesting that researchers might be cutting corners after coming under pressure from authorities to deliver.

"This morning, for the first time in the world, a vaccine against the new coronavirus was registered" in Russia, he said during a televised video conference call with government ministers.

"I know that it is quite effective, that it gives sustainable immunity," he said.

He said one of his daughters had been inoculated with the vaccine, developed by the Gamaleya research institute in coordination with the Russian defence ministry.

"In this sense she took part in the experiment," Putin said, adding that she had a slight temperature after a second injection and "that's all".

"What counts most is for us to be able to ensure the unconditional safety of the use of this vaccine and its efficiency in the future. I hope that this will be accomplished," Putin said.

Health Minister Mikhail Murashko said that clinical trials involving several thousand participants would continue.

Tatyana Golikova, a deputy prime minister in charge of health issues, said officials hoped that vaccinations of medical staff could begin soon.

"We really hope that the vaccine can be produced in September, or even at the end of August or beginning of September, and the first category to be vaccinated will be medical personnel," she said, quoted by Russian news agencies.

- Viral vector vaccine -

Russia has been pushing hard to quickly develop a coronavirus vaccine and said earlier this month it hoped to launch mass production within weeks and turn out "several million" doses per month by next year.

The World Health Organization last week urged Russia to follow established guidelines and go "through all the stages" necessary to develop a safe vaccine.

Spokesman Christian Lindmeier told reporters at the time that the WHO had not been officially notified of any Russian vaccine on the verge of being deployed.

The pandemic has seen an unprecedented mobilisation of funding and research to rush through a vaccine that can protect billions of people worldwide.

The vaccine developed by Russia is a so-called viral vector vaccine, meaning it employs another virus to carry the DNA encoding of the needed immune response into cells.

Gamaleya's vaccine is based on the adenovirus, a similar technology to the coronavirus vaccine prototype developed by China's CanSino.

The state-run Gamaleya institute came under fire after researchers and its director injected themselves with the prototype several months ago, with specialists criticising the move as an unorthodox and rushed way of starting human trials.

Moscow has dismissed allegations from Britain, the United States and Canada that a hacking group linked to Russian intelligence services tried to steal information about a coronavirus vaccine from labs in the West.

With more than 897,000 confirmed infections, Russia's coronavirus caseload is currently fourth in the world after the United States, Brazil and India.

More From: Capital FM

Don't Miss

AllAfrica publishes around 900 reports a day from more than 140 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.